Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement
- PMID: 38462571
- DOI: 10.1007/s00428-024-03774-z
Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement
Abstract
BCL6-rearrangement (BCL6-R) is associated with a favorable prognosis of follicular lymphoma (FL), but the mechanism is unknown. We analyzed the clinicopathological, immune microenvironment (immune checkpoint, immuno-oncology markers), and mutational profiles of 10 BCL6-R-positive FL, and 19 BCL6-R-positive diffuse large B-cell lymphoma (DLBCL) cases (both BCL2-R and MYC-R negative). A custom-made panel included 168 genes related to aggressive B-cell lymphomas and FL. FL cases were nodal, histological grade 3A in 70%, low Ki67; and had a favorable overall and progression-free survival. DLBCL cases were extranodal in 60%, IPI high in 63%, non-GCB in 60%, EBER-negative; and had a progression-free survival comparable to that of DLBCL NOS. The microenvironment had variable infiltration of M2-like tumor-associated macrophages (TAMs) that were CD163, CSF1R, LAIR1, PD-L1, and CD85A (LILRB3) positive; but had low IL10 and PTX3 expression. In comparison to FL, DLBCL had higher TAMs, IL10, and PTX3 expression. Both lymphoma subtypes shared a common mutational profile with mutations in relevant pathogenic genes such as KMT2D, OSBPL10, CREBBP, and HLA-B (related to chromatin remodeling, metabolism, epigenetic modification, and antigen presentation). FL cases were characterized by a higher frequency of mutations of ARID1B, ATM, CD36, RHOA, PLOD2, and PRPRD (p < 0.05). DLBCL cases were characterized by mutations of BTG2, and PIM1; and mutations of HIST1H1E and MFHAS1 to disease progression (p < 0.05). Interestingly, mutations of genes usually associated with poor prognosis, such as NOTCH1/2 and CDKN2A, were infrequent in both lymphoma subtypes. Some high-confidence variant calls were likely oncogenic, loss-of-function. MYD88 L265P gain-of-function was found in 32% of DLBCL. In conclusion, both BCL6-R-positive FL and BCL6-R-positive DLBCL had a common mutational profile; but also, differences. DLBCL cases had a higher density of microenvironment markers.
Keywords: BCL6-rearrangement; Diffuse large B-cell lymphoma; Follicular lymphoma; High-confidence variant calls; Mutational profile; Prognosis.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Comparison of the Mutational Profile between BCL2- and BCL6-Rearrangement Positive Follicular Lymphoma.J Mol Diagn. 2025 Aug;27(8):796-807. doi: 10.1016/j.jmoldx.2025.05.002. Epub 2025 Jun 5. J Mol Diagn. 2025. PMID: 40482882
-
Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.Int J Med Sci. 2019 Apr 20;16(4):556-566. doi: 10.7150/ijms.27610. eCollection 2019. Int J Med Sci. 2019. PMID: 31171907 Free PMC article.
-
Clinical significance of 'double-hit' and 'double-expression' lymphomas.J Clin Pathol. 2020 Mar;73(3):126-138. doi: 10.1136/jclinpath-2019-206199. Epub 2019 Oct 15. J Clin Pathol. 2020. PMID: 31615842
-
Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity.Am J Surg Pathol. 2022 Jan 1;46(1):71-82. doi: 10.1097/PAS.0000000000001750. Am J Surg Pathol. 2022. PMID: 34392269 Review.
-
Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.World J Surg Oncol. 2023 Oct 26;21(1):342. doi: 10.1186/s12957-023-03234-z. World J Surg Oncol. 2023. PMID: 37884941 Free PMC article. Review.
Cited by
-
Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks.Cancers (Basel). 2024 Dec 19;16(24):4230. doi: 10.3390/cancers16244230. Cancers (Basel). 2024. PMID: 39766129 Free PMC article.
-
Profiles of Circulating Exosomal miRNA in Patients with SAPHO Patients by High-Throughput Sequencing.Comb Chem High Throughput Screen. 2025;28(7):1193-1204. doi: 10.2174/0113862073289083240425114858. Comb Chem High Throughput Screen. 2025. PMID: 38752639
References
-
- Biagi JJ, Seymour JF (2002) Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 99:4265–4275. https://doi.org/10.1182/blood.v99.12.4265 - DOI - PubMed
-
- Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107:265–276. https://doi.org/10.1182/blood-2005-06-2508 - DOI - PubMed - PMC
-
- Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadie M, Simonetti A, Lutz JM, Berrino F, Group HW (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116:3724–3734. https://doi.org/10.1182/blood-2010-05-282632 - DOI - PubMed
-
- Shirley MH, Sayeed S, Barnes I, Finlayson A, Ali R (2013) Incidence of haematological malignancies by ethnic group in England, 2001–7. Br J Haematol 163:465–477. https://doi.org/10.1111/bjh.12562 - DOI - PubMed
-
- J.C. FASA (2022) Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma UpToDate
MeSH terms
Substances
Grants and funding
- 23K06454/the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 15K19061/the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 18K15100/Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 24590430/Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 2021-B04/Tokai University School of Medicine research incentive assistant plan
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous